Eli Lilly to acquire Ajax Therapeutics for up to $2.3 billion
Apr 27, 2026 4:14 AM
April 27 (Reuters) - Eli Lilly ( LLY ) said on Monday it would buy privately-held blood cancer treatment developer Ajax Therapeutics for up to $2.3 billion in cash.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.